By ending the sale of tobacco products in its 7,600 pharmacies, CVS Caremark Corp. is redefining itself as a health-care provider in an environment in which millions of newly insured Americans will be looking for quick and convenient medical care.
CVS Caremark, the largest provider of prescription drugs in the U.S., plans to stop selling cigarettes and tobacco-related products across the nation by Oct. 1 in an effort to support the health of its patients and customers.
Danaher Corp., a maker of everything from dental equipment to water filters, may spend some of its more than $8 billion in takeover firepower on Pall Corp. or Spectris Plc to help boost sales amid the slowest growth in four years.
CVS Caremark Corp., the largest provider of prescription drugs in the U.S., agreed to buy Coram LLC from Apria Healthcare Group Inc. for about $2.1 billion to add specialty infusion services, its biggest deal in five years.
McKesson Corp., the largest U.S. pharmaceutical distributor, rose to its highest value ever after agreeing to buy Germany’s Celesio AG for about 3.9 billion euros ($5.4 billion) to boost its share of the growing global generic- drug market.